Exhibit 4.1
REGISTRATION RIGHTS AGREEMENT
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 14, 2021, is made by and among Twist Bioscience Corporation, a Delaware corporation (“Parent”), and Shareholder Representative Services LLC, a Colorado limited liability company (“Securityholder Representative”), for the benefit of the Holders (as defined below).
WHEREAS, Parent, Chase Acquisition Sub, Inc., a Delaware corporation, Chase Acquisition Sub, LLC, a Delaware limited liability company, iGenomX International Genomics Corporation, a Delaware corporation (the “Company”), and the Securityholder Representative have entered into an Agreement and Plan of Merger and Reorganization, dated as of May 13, 2021 (together with all schedules and exhibits thereto, the “Merger Agreement”), pursuant to which Parent will through the Mergers acquire the Company (together with the other transactions contemplated by the Merger Agreement, the “Transactions”).
WHEREAS, as a result of the First Merger, at the First Effective Time, all of the capital stock of the Company will be cancelled and terminated and converted into the right to receive the consideration set forth in the Merger Agreement.
WHEREAS, as a condition and inducement to the willingness of the Company to enter into the Merger Agreement, the Company has required that Parent enter into this Agreement.
WHEREAS, in order to induce the Company to consummate the First Merger and the other Transactions, Parent is willing to enter into this Agreement.
AGREEMENT
NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows effective at, and is contingent upon the consummation of, the First Effective Time.:
1. Definitions. All capitalized terms that are used but not defined herein shall have the respective meanings ascribed to them in the Merger Agreement. For all purposes of and under this Agreement, the following capitalized terms shall have the respective meanings below:
(a) “Exchange Act” means the Securities Exchange Act of 1934, as amended.
(b) “Form S-3” means a registration statement on Form S-3 promulgated by the SEC under the Securities Act, as such form is in effect on the date hereof, or any successor or replacement form of registration statement promulgated by the SEC under the Securities Act from and after the date hereof, in any such case which similarly permits inclusion or incorporation of substantial information by reference to other documents filed by Parent with the SEC.
(c) “Holder” means a Company Securityholder to whom shares of Parent Common Stock are issued in connection with the First Merger pursuant to the Merger Agreement or a transferee to whom registration rights granted under this Agreement are assigned pursuant to Section 6 hereof.
(d) “Registrable Securities” means, (i) for each Holder, its Subject Securities, and (ii) for all Holders, the sum of the Subject Securities held by them as a group; provided, however, that the Subject Securities held by a particular Holder shall cease to be Registrable Securities (x) after the Registration Statement with respect to the sale of such securities shall have been declared effective under the Securities Act and such securities shall have been disposed of in accordance with the Registration